Related Experiment Video
Updated: Aug 6, 2026
05:59
High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Sodium oxybate improves excessive daytime sleepiness in narcolepsy
Jed Black1, William C Houghton
1Stanford Sleep Disorders Clinic, CA 94305, USA. jedblack@stanford.edu
Sleep
|August 10, 2006
Summary
Sodium oxybate and modafinil effectively treat narcolepsy's excessive daytime sleepiness. When combined, these medications show additive benefits, offering improved wakefulness and reduced sleepiness for patients.
Area of Science:
- Neurology
- Sleep Medicine
- Pharmacology
Background:
- Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness (EDS).
- Modafinil is a commonly prescribed stimulant for EDS in narcolepsy, but some patients require additional treatment.
- Evaluating alternative and adjunctive therapies is crucial for managing narcolepsy symptoms effectively.
Purpose of the Study:
- To compare the efficacy of sodium oxybate monotherapy, modafinil monotherapy, and combination therapy for treating EDS in narcolepsy patients.
- To assess the additive effects of combining sodium oxybate and modafinil.
Main Methods:
- A double-blind, placebo-controlled, multicenter study involving 270 adult narcolepsy patients previously treated with modafinil.
- Patients were randomized to receive either placebo, sodium oxybate, modafinil, or a combination of sodium oxybate and modafinil.
- Efficacy was primarily measured by the Maintenance of Wakefulness Test (MWT) and secondarily by the Epworth Sleepiness Scale (ESS).
Main Results:
- Sodium oxybate monotherapy was found to be as effective as modafinil in improving sleep latency on the MWT.
- The combination of sodium oxybate and modafinil demonstrated an additive effect, significantly increasing sleep latency compared to monotherapy.
- Both sodium oxybate monotherapy and combination therapy led to significant reductions in ESS scores, indicating improved subjective sleepiness.
Conclusions:
- Sodium oxybate is an effective monotherapy for treating excessive daytime sleepiness in narcolepsy.
- Combining sodium oxybate with modafinil provides additive therapeutic benefits for narcolepsy patients with persistent EDS.
- These findings support the use of sodium oxybate as both a standalone and adjunctive treatment option.
Related Concept Videos
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...